Log in to save to my catalogue

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_821489527

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Publication information

Publisher

Waltham, MA: Massachusetts Medical Society

More information

Scope and Contents

Contents

In this study, adding pegylated interferon alfa-2a to imatinib therapy for chronic myeloid leukemia resulted in a greater reduction in the number of cells bearing BCR-ABL in a higher fraction of patients than did imatinib alone. However, pegylated interferon alfa-2a also has toxic effects.
Chronic myeloid leukemia (CML) is characterized by trans...

Alternative Titles

Full title

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_821489527

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_821489527

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1004095

How to access this item